Int J Cardiol. 2013 Feb 13. pii: S0167-5273(13)00070-3. doi: 10.1016/j.ijcard.2013.01.030.
Ng LL, Sandhu JK, Squire IB, Davies JE, Jones DJ.
University of Leicester, Department of Cardiovascular Sciences, Leicester Royal Infirmary, Leicester, United Kingdom; NIHR Leicester Cardiovascular Biomedical Research Unit, Glenfield Hospital, Leicester, United Kingdom.
BACKGROUND: Vitamin D status (VDS) has been linked to mortality and incident acute myocardial infarction (AMI) in healthy cohorts. Associations with recurrent adverse cardiovascular events in those with cardiovascular disease are less clear. Our objective was to assess the prevalence and prognostic impact of VDS on patients presenting with AMI.
METHODS: We measured plasma 25-(OH)D(3) and 25-(OH)D(2) using isotope dilution tandem mass spectrometry, in 1259 AMI patients (908 men, mean age 65.7±12.8years). The primary endpoint was major adverse events (MACE), a composite of death (n=141), heart failure hospitalisation (n=111) and recurrent AMI (n=147) over median follow-up of 550days (range 131-1095). Secondary endpoints were fatal and non-fatal MACE.
RESULTS: Almost 74% of the patients were vitamin D deficient (<20ng/ml 25-(OH)D). Plasma 25-(OH)D existed mainly as 25-(OH)D(3) which varied with month of recruitment. Multivariable survival Cox regression models stratified by recruitment month (adjusted for age, gender, past history of AMI/angina, hypertension, diabetes, hypercholesterolaemia, ECG ST change, Killip class, eGFR, smoking, plasma NTproBNP), showed 25-(OH)D(3) quartile as an independent predictor of MACE(P<0.001) and non-fatal MACE(P<0.01), but not death. Using the lowest 25-(OH)D(3) quartile(<7.3ng/ml) as reference for MACE prediction, the 2nd, 3rd and 4th quartiles showed significantly lower hazard ratios (HR 0.59(P<0.002), 0.58(P<0.001), and 0.59(P<0.003) respectively). For non-fatal MACE prediction, the 2nd, 3rd and 4th 25-(OH)D(3) quartiles were all significantly different from the lowest reference quartile (HR 0.69(P<0.05), 0.54(P<0.003) and 0.59(P<0.014) respectively).
CONCLUSIONS: VDS is prognostic for MACE (predominantly non-fatal MACE) post-AMI, with approximate 40% risk reduction for 25-(OH)D(3) levels above 7.3ng/ml.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.
- Overview Cardiovascular and vitamin D
- Hypothesis: Decreasing Magnesium and increasing CaMg ratio are increasing health problems – 2012 - 2013
- Major ECG abnormalities associated with low vitamin D and death – Sept 2014
- Cardiovascular system benefits from both Omega-3 and vitamin D – Dec 2012
- 14X more likely to die after first cardiovascular event if vitamin D deficient – Nov 2012
- Increased heart attacks in the winter may be due to lack of sunshine – Nov 2012
- 14X more likely to die after first cardiovascular event if vitamin D deficient – Nov 2012 small study
- Cardiovascular disease 50 % more likely if low vitamin D – meta-analysis Nov 2012
- Heart Failure early death 2X more likely if less than 20 nanograms of vitamin D – June 2012
- Half as many heart deaths for those with high levels of vitamin D – meta-analysis Sept 2012
- Vitamin D intervention reduced death due the heart failure by 32 percent – Feb 2012
- All items in Cardiovascular and Vitamin D
- Intervention Clinical Trials for (heart OR cardiovascular) and "vitamin D" 230 as of Nov 2012